Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
226 articles on this topic
-

When to Take MOTS-c: What Human Research Says
No human trial has shown that morning, night, or a workout window is best. The exercise link is real but easy to overread: researchers measured the MOTS-c people made themselves, not the effect of a timed dose.
-

BPC-157 WADA Status: Prohibited All Year Round
If you're tested in your sport, the answer is short. BPC-157 is prohibited all year round, a prescription doesn't change that, and the one exemption that could is unlikely to be granted, by USADA's own account.
-

Compounded Medication Recall: Check the Lot
A recall usually applies to one pharmacy, one preparation and specific lot numbers—not every compounded medication. Here is how to check a vial and reach the people responsible for it.
-

How to Use PT-141: It's As-Needed, Not Daily
PT-141 is taken before anticipated activity rather than on a daily schedule. Here is what the approved label sets out, what a compounded vial changes, and what the prescriber decides.
-

Kisspeptin-54 vs Kisspeptin-10: Why Length Matters
Kisspeptin-54 is the whole peptide; kisspeptin-10 is its last ten amino acids. The long one lasts about seven times longer in the blood, and that one fact explains which studies used which.
-

MOTS-c Cycle: Nobody Has Established One
The word “cycle” came from bodybuilding, not from any MOTS-c research. Every study that has actually given the peptide — the mouse work, and the one human trial now running — dosed it straight through, with no weeks off.
-

Sermorelin for Muscle Growth: Evidence Is Limited
Sermorelin can raise growth-hormone pulses, but that does not automatically build muscle. The human studies are small, and they have not shown a reliable strength benefit.
-

Tesamorelin Cost: Brand vs. Compounded Prices
Public brand benchmarks run from about $6,000 a month at wholesale list price to roughly $10,709 for a 28-day cash quote. Insurance may bring that down for HIV-associated lipodystrophy; compounded tesamorelin follows a separate cash-pay path.
-

Tirzepatide 3 Month Supply: What You Get
Three months usually means a series of monthly dose packages, not one vial kept open for 90 days. The prescription, storage dates, and billing period each answer a different part of the question.
-

What Is Cagrilintide? The Amylin Half of CagriSema
Cagrilintide is an experimental copy of the appetite hormone amylin, and the other half of Novo Nordisk's CagriSema. It is not approved, it is not sold here, and a US decision is expected before the end of 2026.
-

How to Get Sermorelin Prescribed: Four Steps
Getting a sermorelin prescription starts with a compound-specific medical intake, followed by a real clinician's review. Symptoms and labs can inform the decision, but neither guarantees a prescription.
-

BPC-157 Dosage by Body Weight: No Human Formula
There is no validated weight-based BPC-157 dose for people. The micrograms-per-kilogram numbers online were lifted from rat experiments, not human dose-finding trials.
-

GHK-Cu Studies Find a Gap in Human Evidence
A new systematic review found only two randomized human GHK-Cu trials among 20 eligible studies, and both were topical. The injectable claims run well ahead of the clinical evidence.
-

Is Sermorelin a Steroid? No, It Is a Peptide
Sermorelin is a peptide signal that asks the pituitary to release growth hormone. It is neither an anabolic steroid nor HGH itself, though sports drug-testing rules still matter.
-

Kisspeptin for Women: What the Research Shows
Kisspeptin has been given to women in a handful of small hospital trials — to mature eggs during IVF, to restart stalled hormone signalling, and once to watch the brain respond to sexual cues. Here is what those studies found, and what they did not.
-

TB-500 Half-Life: The Honest Answer Is Unknown
There is no reliable human half-life for the TB-500 fragment. The familiar one-to-two-hour estimate comes from the 44-amino-acid recombinant study molecule NL005, tested by a different route.
-

Tesamorelin Cycle: Why Doctors Talk About Duration
There is no on-and-off tesamorelin cycle in the research. The trials ran it daily for 26 weeks and then 52 — and when people stopped, the visceral fat came back.
-

GLP-1 Heart Failure Guidelines Changed in 2026
Europe's 2026 ESC guideline now says semaglutide or tirzepatide should be considered for a narrow group with symptomatic heart failure and obesity. It is an option for a cardiologist to weigh, not a direction to start either drug on your own.
-

How to Choose a Tirzepatide Provider: 7 Checks
Most of the difference between a careful service and a careless one shows up before a vial ever arrives — in who reads your history, who makes the medicine, and whether anyone answers afterwards.
-

CJC-1295 Ipamorelin for Muscle Growth: No Trial
These peptides can raise signals along the growth hormone pathway, but no human trial has shown that the pair builds muscle or increases strength. The honest case is a plausible mechanism, not a bodybuilding result.
Page 5 of 12 · 226 articles